LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Mar 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-03-03

Reporting Person: MYERS STEVEN S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-03-03	Common Stock, par value $0.001 per share	P	195312	$1.28	Acquired	889300	Direct
2011-03-03	Common Stock, par value $0.001 per share	P	195313	$1.28	Acquired	195313	Indirect

Footnotes

F1: The reporting person participated in a private placement of NeoStem, Inc. (the "Company") common stock (the "Private
Placement") due to restrictions on his purchasing the Company's common stock in the open market and in response to his
desire to increase his ownership in the Company.

F2: Purchased by the reporting person's IRA in connection with the Private Placement. The shares of common stock were purchased
at the then market price of the common stock of the Company under a subscription agreement entered into on February 25,
2011.

F3: Purchased by the Steven S. Myers Revocable Trust dated December 1, 2000 in connection with the Private Placement. The shares
of common stock were purchased at the then market price of the common stock of the Company under a subscription agreement
entered into on February 25, 2011.